Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis

Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis

Abstract Background Novel biological and precision therapies and their associated predictive biomarker tests offer opportunities for increased tumor response, reduced adverse effects, and improved survival. This systematic review determined if there are socio-economic inequalities in utilization of...

Full description

Bibliographic Details
Main Authors: Ruth P. Norris, Rosie Dew, Linda Sharp, Alastair Greystoke, Stephen Rice, Kristina Johnell, Adam Todd
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Medicine
Subjects:
Precision medicine
Molecular targeted therapy
Immunotherapy
Biological therapy
Pharmacogenomic testing
Drug utilization
Online Access:http://link.springer.com/article/10.1186/s12916-020-01753-0

Internet

http://link.springer.com/article/10.1186/s12916-020-01753-0

Similar Items